Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume 42, Issue 17, Pages 1698-1706
Publisher
Oxford University Press (OUP)
Online
2021-02-20
DOI
10.1093/eurheartj/ehab141
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predicting Adverse Events beyond Stroke and Bleeding with the ABC-Stroke and ABC-Bleeding Scores in Patients with Atrial Fibrillation: The Murcia AF Project
- (2020) Anny Camelo-Castillo et al. THROMBOSIS AND HAEMOSTASIS
- Growth Differentiation Factor-15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized with COVID-19
- (2020) Peder L. Myhre et al. CIRCULATION
- 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)
- (2020) Gerhard Hindricks et al. EUROPEAN HEART JOURNAL
- Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation
- (2020) Ken Okumura et al. NEW ENGLAND JOURNAL OF MEDICINE
- Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients with Atrial Fibrillation in ENGAGE AF-TIMI 48
- (2019) David Douglas Berg et al. CIRCULATION
- Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation
- (2018) Tze-Fan Chao et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Antithrombotic Therapy for Atrial Fibrillation
- (2018) Gregory Y.H. Lip et al. CHEST
- Long-term bleeding risk prediction in ‘real world’ patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores
- (2017) Vanessa Roldán et al. THROMBOSIS AND HAEMOSTASIS
- Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time
- (2017) Ziad Hijazi et al. Journal of the American Heart Association
- The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation
- (2016) Ziad Hijazi et al. EUROPEAN HEART JOURNAL
- The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study
- (2016) Ziad Hijazi et al. LANCET
- Cardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial Fibrillation
- (2016) Christian T. Ruff et al. JAMA Cardiology
- Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation
- (2014) Lars Wallentin et al. CIRCULATION
- Importance of persistent elevation of cardiac biomarkers in atrial fibrillation: a RE-LY substudy
- (2014) Ziad Hijazi et al. HEART
- Biomarkers in atrial fibrillation: a clinical review
- (2013) Z. Hijazi et al. EUROPEAN HEART JOURNAL
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serial Measurement of Growth-Differentiation Factor-15 in Heart Failure
- (2010) Inder S. Anand et al. CIRCULATION
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More